Deep Venous Thrombosis and Long Term Complications

Condition(s) studied

Investigational drug(s) / intervention(s)

Blood sample and Ultrasound examination: The ultrasound examination is a non-invasive procedure with no risks, adverse reactions, or discomforts associated with the examination. The study blood samples are mostly obtained at the same time as clinical blood sample collection in order to avoid unnecessary complications. The inclusion and ultrasound examiniation is performed by the patient responsible physician at the Emergency Department. Blood samples during the study period are performed by trained study staff.

Study summary

In this cohort study, the investigators will investigate the concentration of biomarkers, e.g., inflammatory, anti-inflammatory, immunological, senescent, biochemical ratio-calculations, blood cell type, and and long term complications with a 2-year follow-up in patients with first time lower extremity deep venous thrombosis

Eligibility

Primary outcome measure(s)

• Association of suPAR and PTS - 90 days — 90 days
  Association of suPAR and development of PTS in DVT patients from the time of diagnosis and 90 days after diagnosis
• Change in suPAR - 24 months — 24 months
  Change in suPAR level in first-time DVT patients from the time of diagnosis (baseline) to 24 months

Trial sites (1)

More Ove Andersen trials in Denmark